Applovin Corp (APP) stock saw a modest uptick, ending the day at $363.1 which represents a slight increase of $0.58 or 0.16% from the prior close of $362.52. The stock opened at $364.3 and touched a ...
The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...
Digital Turbine Inc (APPS) stock saw a modest uptick, ending the day at $2.46 which represents a slight increase of $0.21 or 9.33% from the prior close of $2.25. The stock opened at $2.22 and touched ...